Drugs / xHyA
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT07458685 Comparator | Sep 2022 → Jul 2025 | — | University of Milan | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | xHyA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07458685 ↗ |
| Known as | xHyA gel | “The xHyA gel is contained in a 1.2 mL sterile cartridge containing highly purified 1.6% high molecular weight cross-linked HA and 0.2% natural HA to be injected with a 23G blunt needle.” NCT07458685 ↗ |